期刊名称：NEUROSCIENCE BULLETIN
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Neuroscience Bulletin is sponsored by the Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences, the Chinese Society for Neuroscience. Neuroscience Bulletin is an official journal of the Chinese Society for Neuroscience and published bimonthly by Science Press, China.
Neuroscience Bulletin is the proceedings of the Chinese Society for Neuroscience, aims to reflect the advanced researches in the field of neuroscience and to promote the academic communication and development instantly. Neuroscience Bulletin publishes original fundamental and clinical experimental research articles in the fields of neuroscience. Beside Original research papers, the journal also provides columns as Communications, Experimental methods, Review and Progress. All articles are published only in English. Most of the published articles are sourced from mainly neuroscience laboratory in China, and a large proportion of the researches involved in the published articles are granted by funds. Since it is founded in 1998 (the English edition was founded in 2006), the journal has produced obvious social effect, and it possesses steady readership now. It is recognized as one of the excellent publications in Chinese neuroscience research.
Neuroscience Bulletin is indexed/abstracted by Science Citation Index Expanded (SCI-E, available as the Web of Science), Neuroscience Citation Index, Biological Abstracts, and Biosis Previews databases. It is also indexed/abstracted by Medline/PubMed, Chemical Abstracts, Index Medicus, Excerpta Medica, SCOPUS, IndexCopernicus, Chinese Science Citation Database (CSCD), Chinese National Knowledge Infrastructure (CNKI) and Wanfang database. It is the source journal of Chinese scientific and technological paper citation and Chinese academic journal general value database.
Neuroscience Bulletin has cooperated with Springer Science+Business Media for publishing on Springerlink since 2008.
Neuroscience Bulletin is distributed domestically and internationally by Shanghai post office and Springer, respectively. Post office code number is 4-608. Domestic price is RMB 50.
Administration: Chinese Academy of Sciences
Sponsors: Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, the Chinese Society for Neuroscience
Editor-in-Chief: Shumin Duan
Publication Number: ISSN 1673-7067, CN 31-1975/R
Publication Frequency: Bimonthly
Address of Editorial Office: 319 YueYang Road, Building 31B, Room 405, Shanghai 200031, China.
Phone: +86-21-54922863; Fax: +86-21-54922833
E-mail: nsb@sibs.ac.cn
Website: http://www.neurosci.cn
Instructions to Authors
|
Manuscripts should be submitted through our online submission system, ScholarOne Manuscripts, at http://mc03.manuscriptcentral.com/nsb or http://www.neurosci.cn.
Notice for Online Submission:
You need to CREATE your own account (USER ID and PASSWORD) the first time you use this system. Then LOG ON to the server using your USER ID and PASSWORD, and submit your manuscript according to the instructions provided. If you forget your USER ID or PASSWORD, please use the PASSWORD HELP, enter your e-mail address to receive an e-mail with your account information.
If you cannot access the online system, please e-mail your manuscript to the Editorial Office (nsb@sibs.ac.cn), and we will upload the file as your proxy.
Manuscript file types that we accept for online submission include Word, WordPerfect, and TXT. For Figure submission, we accept JPEG, TIFF, or AI files. Required items differ for each article type and are specified during the submission process.
The submitted manuscript should be accompanied with a signed “Neuroscience Bulletin copyright transfer statement and submission form” stating that all work is original, has not been published previously, and is not under consideration for publication elsewhere. The corresponding author responsible for the originality, legality and validity of the work must sign the form.
Authors can refer to a recent issue of Neuroscience Bulletin to view the general layout. The entire manuscript text should be double-spaced with font Arial 12. All pages should be numbered consecutively. Abbreviations should be kept to a minimum. All abbreviations should be accompanied by their full names on their first appearance in the text, in parentheses. All quantities and units should be expressed according to international standards, and SI units must be used throughout. When an Arabic number precedes an SI unit, the unit symbol should be used rather than its full name, such as 2 s (two seconds), 2 min (2 minutes), and 2 h (two hours). Symbols are not followed by a period (e.g., min, not min.). Gene symbols should be italicized; protein products of the loci are not italicized.
Manuscripts must be written in clear and concise English and be intelligible to a broad readership. Prior to submission, authors may benefit from having their manuscript reviewed for clarity by colleagues and/or by using one of the many English language-editing services that are available. | |
| Top |
|
Manuscript Preparation |
|
NB considers manuscripts of the following types:
Research Article
A research article contains original research materials and presents compelling data on conceptual advances in any area of neuroscience. The total character count of all sections of the main text (including references and figure legends but excluding supplemental data) should not exceed 60,000, including spaces. Up to 8 figures and/or tables are allowed for the entire manuscript. The minimum requirement of a submitted research article is 40,000 characters total and at least 6 figures. The submitted manuscript should be a substantial novel research study, organizing a story with complex mechanisms elucidated using multiple techniques or approaches. It should provide mechanistic insights into a particular aspect of neuroscience field. References are limited to 100.
Report
In addition to research articles, NB also publishes short-format papers that report single exciting message in a particular field of neuroscience. Research observations should contain enough novelty and demonstrate physiological/functional significance. Manuscripts for reports can be up to approximately 30,000 characters (including spaces). The number of Figures in Reports should be limited to 4. Reports follow the same general organization as research articles except that the sections of Results and Discussion should be combined (denoted as Results and Discussion). References are limited to 50.
Review
Authoritative reviews contribute greatly to our journal and we are interested in comprehensive articles that are fairly and well written to describe recent development in any field of neuroscience. The authors are expected to cover controversies in the field and propose their own viewpoints in an unbiased and justifiable way. Reviews are typically at the similar length with research articles and schematic illustrations are strongly encouraged. In particular, the scope of the review should not be dominated by the authors’ own work.
Others
All other types of articles including Research Highlight, Perspective, Brief Communication, and Method are also being considered upon enquiry. The article type should be specified in the author’s cover letter. For Brief Communication and Method, the article should begin with an unreferenced abstract about 100 words. For Perspective, Brief Communication, and Method, the total character count should not exceed 20,000 and the display items should be limited to 2. Subheadings are discouraged. References are limited to 20. For Perspective, the article should contain discussion on recent primary research literature similarly as Review. Yet, Perspective is shorter in length and focuses on a narrower scope. It is possible that in Perspective authors advocate a position over a controversial issue or a speculative hypothesis. For Brief Communication, the article reports a concise message conveyed by primary research data of high quality and broad interest. In addition, please note that NB no longer accepts Method on neurosurgery pathway, surgical techniques, or any other clinical related technical studies. On the other hand, NB welcomes Method discussing new advances on research techniques in any field of basic neuroscience (For a glance, please see our Special Issue on “new techniques and approaches for neuroscience”).
Please note that NB intends to publish high quality research articles as the major part of the journal. Short reports and articles of other formats are only considered if the research work provides a major scientific breakthrough. The number of these other articles is limited in every issue.
Accepted and published manuscripts are expected to comply with journal policies on these formats and NB editors reserve the right to return manuscripts that are not in accordance with the instructions. During initial submission, NB will consider manuscripts based on the scientific merit even if they slightly exceed the required length. Once accepted for publication, however, the authors will be asked to shorten the manuscript to fit the journal's format. | |
| Top |
|
General Article Organization |
|
Submitted manuscripts should be divided into the following sections:
Title Page
The title page includes a full title that is short, informative, and does not contain any abbreviation. Names and affiliations of all authors should be listed. The complete address for correspondence such as postal, email, phone, and fax number should also be included. A running title of less than 50 characters including spaces should be listed here and the authors should provide 3 to 8 keywords separated by semicolons here as well.
Abstract
Abstracts should be a single paragraph written in English with no more than 150 words. The Abstract should summarize key research findings in the manuscript using concise and proper English. It should also be comprehensible to readers before they have read the paper. Abbreviations should be avoided where possible (as for the title). Reference citations within the abstract are not permitted.
Introduction
This section should provide a concise yet comprehensive summary of the background of the subject. An extensive review of the literature is usually not appropriate, and the text should be succinct with no subheadings. Citation of the primary literature is required where appropriate.
Materials and Methods
Sufficient experimental details are required in this section and all experiments involving human subjects must be conducted in accordance with principles of the Declaration of Helsinki and approved by the institutional ethics committee. When experimental animals are used, this section must guarantee that the experiments were conducted in accordance with national legislation and associated guidelines. Full details of any anesthetic or analgesic dose and treatment must be given. Methods for statistical analyses and any non-standard techniques should be described and justified.
Results
Results should be written in clear and concise language. Figures should be used to summarize or illustrate the important findings. Quantitative observations illustrated by graphs or tables are encouraged. Subheadings are required in this section.
Discussion
The discussion should deal with the interpretation of the results, accompanied by an assessment of their significance. A repeated description of the results should be avoided and any potential implications of the results should be stated in this section.
Acknowledgements
Acknowledgements should be placed at the end of the text and state the contributions of both individuals and supporting institutions. They should be as brief as courtesy allows. Grant numbers are permissible.
References
Place citations as numbers in superscript in the text and follow the style below. “unpublished data”, “electronic material” or “personal communications” should not be used as references, although written communications may be inserted in the text (in parentheses). Articles in press can be cited at submission, but all references should been published at the publication of the accepted paper. Authors are responsible to make sure that the literature is accurately cited and discussed. The titles of journals should be abbreviated according to the “List of Journals Indexed” in Index Medicus. List all the authors up to six, but if the number exceeds six, add “et al.”.
Please note that an endnote reference style for NB is provided for download in NB website for authors. To illustrate here, references should be numbered consecutively using Arabic numerals in the order of appearance in the text, using the following style:
[1] Koob GF, Sanna PP, Bloom FE. Neuroscience of addiction. Neuron 1998, 21: 467-476.
[2] Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, et al.
The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997, 389: 994-999.
Example of books and other monographs:
[3] Paxinos G, Watson G. The Rat Brain in Stereotaxic Coordinates. 4th ed.
San Diego: Academic Press, 1999: 96-101.
Figures, legends, and tables
Figures and Supplementary Figures should be numbered in Arabic numerals consecutively in the order they are mentioned in the text. Each figure must contain a heading. They should be of high quality (400 dpi) in TIFF or JPEG format. Please make sure that a sufficiently high resolution is required for the figure once the whole figure is downsized in print and at which that essential details are still visible. If figures are divided into parts, each part should be labeled as well with a letter. Scale bars should be used and the length of the bar should be defined in the legend. Color figures are welcome. When Figures contain microscopy images, please note that NB prefers the use of colors for color-blind readers such as magenta instead of red.
Figure legends should be concise and contain sufficient information for the readers to understand the data in the Figure instead of going back to the text. In the legends, all symbols and abbreviations used in the figure should be defined. Legends should not contain too much of the experimental details as this information should be given in the Materials and Methods section. Legends should be limited to 300 words in length.
Tables should be included in a separate word file and numbered consecutively with Arabic numerals. Tables should be self-explanatory. A brief descriptive title and footnotes should be provided.
Supplementary Information
Due to space or format constraints, the authors may submit additional peer-reviewed materials as supplementary information. These include figures, movies, or tables posted on the journal’s web site and available for the readers upon publication. Legends explaining these results should be included. Supplementary information should help the readers to understand the paper, yet without it the article should be complete and self-explanatory. Please refer to the supplementary item in the main body text. | |
| Top |
|
Further Manuscript Processing |
|
Manuscript Revision
Upon peer-reviews, the authors may be asked to revise the manuscript. If the authors have substantial reasons to believe that their manuscript was treated unfairly, they may appeal for reconsideration. Revision should be completed within four (minor revision) or eight weeks (major revision). The authors should provide a cover letter and a point-to-point response for addressing the reviewers’ comments. The editor will notify the corresponding author upon the acceptance of the manuscript. Accepted papers will be processed to advanced online publication as soon as possible.
Rejected Manuscripts
If a manuscript is not accepted for publication, it will be returned to the author within 2 months. Rejected manuscripts should not be re-submitted unless substantial amount of changes have occurred on the manuscript.
Proofs
A PDF proof will be sent to the authors for them to correct last minute errors on the manuscript.
Page Charges
Page charges for the printed form are as follows: RMB400 for each text page, RMB500 for each page containing black-and-white figures, RMB1500 for the first page containing color figures, RMB1000 for the second color figure page, and RMB800 for the rest. The corresponding author will receive an invoice on all the publication-related charges once the manuscript is accepted for publication and enters the editing process.
If you are in abroad, make checks or money orders payable to:
U. S. Intermediary Bank: JPMORGAN CHASE BANK, N.A.
SWIFT BIC: CHASUS33
Beneficiary’s Bank: AGRICULTURAL BANK OF CHINA
SWIFT BIC: ABOCCNBJ
Beneficiary’s A/C NO. : 033924-00801048006
Beneficiary’s Name: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES
Beneficiary’s Address: 320 Yue Yang Road, Shanghai, China
If you are in China, make checks or money orders payable to:
Beneficiary’s Name (帐户名称): Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences (中国科学院上海生命科学研究院)
Beneficiary’s A/C NO. (帐号): 033924-00801048006
Beneficiary’s Bank(开户行): Fenglin Branch of Xuhui District, Agricultural Bank of China (农行徐汇区枫林支行)
If you are in China, payment can also be mailed by Post Office to the Editorial Office of Neuroscience Bulletin.
Editorial Office of Neuroscience Bulletin (《神经科学通报》编辑部收):
Room 405, Building 31B, 319 YueYang Road, Shanghai 200031, China (200031, 上海市岳阳路319号31B楼405室).
Tel: +86-21-54922863
Fax: +86-21-54922833
E-mail: nsb@sibs.ac.cn | |
| Top |
(Updated on November 2013)
Editorial Board
Editor-in-Chief
Shumin Duan, Zhejiang University, Hangzhou, China
Consulting Editors
Yizhang Chen, Second Military Medical University, Shanghai, China
Muming Poo, University of California-Berkeley, USA
Larry R. Squire, University of California-San Diego, USA
Charles F. Stevens, The Salk Institute, San Diego, USA
Xiongli Yang, Fudan University, Shanghai, China
Executive Associate Editor
Iain C. Bruce, Zhejiang University, Hangzhou, China
Associate Editors
Zhong Chen, Zhejiang University, Hangzhou, China
Tianming Gao, South Medical University, Guangzhou, China
Shihui Han, Peking University, Beijing, China
Cheng He, Second Military Medical University, Shanghai, China
Margaret. Ho, Tongji University, Shanghai, China
Ru-Rong Ji, Duke University,Durham, USA
Tianzi Jiang, Institute of Automation, CAS, Beijing, China
Tao Li, West China Hospital, Sichuan University, Chengdu, China
Mengsheng Qiu, Hangzhou Normal University, Hangzhou, China
Fu-Dong Shi, St. Joseph’s Hospital and Medical Center, Phoenix, USA
You Wan, Peking University, Beijing, China
Jian-Zhi Wang, Huazhong University of Science and Technology, Wuhan, China
Zhiying Wu, Huashan Hospital; Shanghai Medical College,Fudan University, Shanghai, China
Tianle Xu, Shanghai Jiaotong University, Shanghai, China
Dai Zhang, Peking University, Beijing, China
Zhijun Zhang, Medical School of Southeast University
Chunjiu Zhong, Fudan University, Shanghai, China
Yimin Zou, University of California-San Diego, USA
Editorial Board
Philippe Ascher, Université Paris, Paris, France
Ben A. Barres, Stanford University, San Francisco, USA
Guo-Qiang Bi, University of Science and Technology of China, Hefei, China
Ying-Shing Chan, The University of Hong Kong, Hong Kong, China
Jun Chen, The Fourth Military Medical University, Xi'an, China
Sheng-Di Chen, Shanghai Jiaotong University, Shanghai, China
Yiping Du, Zhejiang University, Hangzhou, China
Ming Fan, Academy of Military Medical Sciences, Beijing, China
Richard S. Frackowiak, University of Lausanne, Lausanne, Switzerland
Tamás F. Freund, Hungarian Academy of Sciences, Budapest, Hungary
Charles Gilbert, The Rockefeller University, New York, USA
Xiaosong Gu, Nantong University, Nantong, China
Aike Guo, Institute of Neuroscience, CAS, Shanghai, China
Philip G Haydon, Tufts University School of Medicine, Boston, USA
Joe Herbert, University of Cambridge, Cambridge, UK
Zhi-An Hu, Third Military Medical University, Chongqing, China
Kazuhide Inoue, Kyushu University, Fukuoka, Japan
Yong-Hua Ji, Shanghai University, Shanghai, China
Kai-Da Jiang, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
Yu-Wu Jiang, Department of Paediatrics, Peking University First Hospital, Beijing, China
Helmut Kettenmann, Max-Delbrück Center for Molecular Medicine, Berlin, Germany
O.A. Krishtal, Bogomoletz Institute of Physiology, Kiev, Ukraine
Robert H. LaMotte, Yale University School of Medicine, USA
P. Lavenex, University of Fribourg, Fribourg, Switzerland
Juan Lerma, Consejo Superior de Investigaciones Cientificas-Universidad Miguel Hernández, Alicante, Spain
Bao-Ming Li, Nanchang University, Nanchang, China
Yun-Qing Li, The Fourth Military Medical University, Xi'an, China
David J. Linden, Johns Hopkins University, Baltimore, USA
Stuart A. Lipton, Sanford-Burnham Medical Research Institute and University of California San Diego, La Jolla, USA
Bai Lu, GlaxoSmithKline (China) Investment Co., Ltd., Shanghai, China
Yi-Cheng Lu, Changzheng Hospital, Second Military Medical University, Shanghai, China
B.M. Lumb, University of Bristol, Bristol, UK
Jian-Hong Luo, Zhejiang University, Hangzhou, China
Zhen-Ge Luo, Institute of Neuroscience, CAS, Shanghai, China
Lan Ma, Fudan University, Shanghai, China
Robert C. Malenka, Stanford University, Stanford , USA
M.S. Malmierca, Universidad de Salamanca, Salamanca, Spain
John H.R. Maunsell, Harvard Medical School, Boston, USA
Lin Mei, Georgia Health Sciences University, Augusta, USA
Earl K. Miller, Massachusetts Institute of Technology, Cambridge, USA
Enrico Mugnaini, Northwestern University,Feinberg School of Medicine, Chicago, USA
Vladimir Parpura, University of Alabama, Tuscaloosa, USA
Bruce R. Ransom, University of Washington, Seattle, USA
Yi Rao, Peking University, Beijing, China
F. Rossi, Università di Torino, Torino, Italy
Huai-Zhen Ruan, Third Military Medical University, Chongqing, China
Tom. E. Salt, University College London, London, UK
Joshua R. Sanes, Harvard University, Boston, USA
Michael N. Shadlen, University of Washington, Seattle, USA
Morgan Sheng, Genentech, Inc., South San Francisco, USA
Sangram S. Sisodia, The University of Chicago, Chicago, USA
Peter Somogyi, University of Oxford, Oxford, UK
Feng-Yan Sun, Fudan University, Shanghai, China
Dick F. Swaab, Netherlands Institute for Neuroscience, Amsterdam, Netherlands
Keiji Tanaka, RIKEN Brain Science Institute, Tokyo, Japan
Alexej Verkhratsky, The University of Manchester, Manchester, UK
Steven R. Vincent, University of British Columbia, Vancouver, Canada
Jian-Jun Wang, Nanjing University, Nanjing, China
Wei Wang, Huazhong University of Science and Technology, Wuhan, China
Wei Wang, Zhejiang University, Hangzhou, China
Xu-Chu Weng, Hangzhou Normal University, Hangzhou, China
William Wisden, Imperial College London, London, UK
Chien-Ping Wu, Shanghai Institutes for Biological Sciences, CAS, Shanghai, China
Jun-Xia Xie, Qingdao University, Qingdao, China
Lin Xu, Kunming Institute of Zoology, CAS, Kunming, China
Albert Yu, Peking University, Beijing, China
Hong Zhang, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
Yu-Qiu Zhang, Fudan University, Shanghai, China
Xu Zhang, Institute of Neuroscience, CAS, Shanghai, China
Zhong-Xin Zhao, Changzheng Hospital, Second Military Medical University, Shanghai, China
Ping Zheng, Fudan University, Shanghai, China
Jiang-Ning Zhou, University of Science and Technology of China, Hefei, China
Richard E. Zigmond, Case Western Reserve University, Cleveland, USA
|
